#2319 - Rick Doblin

Rick Doblin, Ph.D., is the founder and president of the
Multidisciplinary Association for Psychedelic Studies (MAPS), a
nonprofit established in 1986 to advance evidence-based psychedelic
therapy and end prohibition. MAPS incubated Lykos Therapeutics
(formerly MAPS Public Benefit Corporation) which is leading drug
development of MDMA-assisted therapy for PTSD.  Learn more
about Psychedelic Science 2025, June 16–20 at the Colorado
Convention Center in Denver, at www.psychedelicscience.org,
and visit www.maps.org for information on MAPS Learn more
about your ad choices. Visit podcastchoices.com/adchoices